Just in: United States approves chloroquine as treatment for COV-19

Just in: United States approves chloroquine as treatment for COV-19

Just in: United States approves chloroquine as treatment for COV-19

Earlier today, President Trump (among others) touted chloroquine as a ready-to-use treatment for the disease.

President Donald Trump said he has asked the FDA to investigate whether certain therapeutic drugs now used for other purposes might hold potential to treat those suffering with COVID-19.

President Trump, she said, "asked for a critical briefing" this week on the drug.

"They've gone through the approval process, that's been approved", he said. He said such a vaccine would have to be thoroughly tested to make sure it would not harm people in the long run.

No drug is specifically approved now for treating COVID-19.

The fact that chloroquine is on the World Health Organization's list of essential drugs for the treatment of malaria also means that it is widely available worldwide, including in developing countries that may have challenges accessing any new medicines developed to treat COVID-19. In a new controlled clinical study conducted in France, doctors found that Hydroxychloroquine is effective in the fight against coronavirus.

Chloroquine offers a simple, affordable and scalable treatment option to coronavirus patients--standing out against next-generation therapeutics and other expensive treatments used to curb the virus.

Researchers said the drugs cleared the virus in the nose and throat of most observed patients in three to six days. "When you go with a brand new drug, you don't know", he said.

Part of that, Hahn said, is exploring drugs that are "already approved for other indications", noting the President's remarks on chloroquine. "All show some evidence of effectiveness against SARS-CoV 2 virus, which causes Covid-19, either in vitro and/or animal studies". The drug has been used in a small number of patients with COVID-19 in an experimental manner, according to Gilead. They recovered, but it's impossible to know whether they would have anyway without the drug.

Remdesivir is said to be "the most promising candidate" for coronavirus treatment.

Professor Raoult said: "We included everyone who was in agreement [to be treated], which was nearly everyone". Several private companies "have now greatly increased by the tens of millions their production of N95 masks that will give our healthcare workers the protection they need". In animal tests, it was "quite effective at preventing infection" and reducing severity of illness and damage to the lungs when given early enough in the course of illness, he said.

36 patients - including 20 treated individuals and 16 infected controls - were enrolled in the study, led by Didier Raoult, an infectious disease expert from l'Institut Hospitalo-Universitaire in Marseille. "But compared to some other drugs it's rather safe", Thorburn says. It targets interleukin-6, which plays a role in inflammation.

On Thursday, President Trump announced that Hydroxychloroquine, a form of chloroquine, had been approved by the FDA and will soon be available for a prescription for the coronavirus outbreak.

Related news

[an error occurred while processing the directive]